CORE DUTIES:

Determine scope, design, plan, and analyze phase 1-4 pharmacokinetic and pharmacodynamics studies, including development of appropriate population PK models, and PK/PD analysis required from a development and regulatory perspective to take a project from its existing or concept stage to commercialization.
Develop and implement modeling and simulation plans for drug development.
Collaborate with project team members and partner CROs to support appropriate pharmacometric analyses (population PK, PK-PD, exposure-response, PBPK, simulations, etc.) to answer development questions

REQUIREMENTS:

Pharm. D./Ph.D. or MS in Pharmacokinetics, Pharmaceutical Sciences, Pharmacology, Chemistry, Biochemistry, or related field with a strong understanding of clinical pharmacology principles.
Significant industry experience (Director: MS and 10+ years of experience) in conduct and/or oversight of clinical pharmacology studies and data analysis.
Professionals with MS and 8+ years experience may be considered for Associate Director level.
Proficient in NONMEM, R, SAS, Monolix, WinNonLin, Microsoft Office Suite.

Director, Pharmacometrics